LaValle to advance scientific strategies and initiatives as part of Life Time's revolutionary MIORA longevity and performance program and clinicCHANHASSEN, Minn., April 29, 2024 /PRNewswire/ -- Life Time (NYSE: LTH) today announced the appointment of James LaValle, clinical pharmacist, C.C.N.M.T. as Chief Science Officer. LaValle will spearhead the development and implementation of scientific initiatives and strategic relationships to support MIORA, Life Time's new longevity and performance program launched ...